Galen Partners

Galen Partners is a healthcare-focused growth equity investment firm. With nearly $1-billion invested over five funds, Galen has helped build more than 70 companies since inception.

Since its establishment in 1990, Galen has created an investment portfolio with an aggregate market value of over $10-billion. The firm follows a tradition of strategic collaboration and partnership with founders of the company and management teams to build healthcare market leaders.

Under the direction of the Managing Directors Philip Borden, David Jahns and Zubeen Shroff, Galen seeks to make investments in high-growth healthcare companies with revenues greater than $10-million and EBITDA of up to $9 million. In September 2020, Steve Cashman, the ex-CCO of InTouch Health, joined the firm as Special Investment Partner.

In 2006, the company relocated its headquarters from New York City's Rockefeller Center to Stamford, Connecticut.

Portfolio Companies
Current and past investments include:
 * Acura Pharmaceuticals
 * Aperio Technologies
 * Cambrooke Therapeutics
 * CBLPath
 * CDx Diagnostics
 * Chamberlin Edmond and Associates
 * Dow Pharmaceutical Sciences (Valeant)
 * EduNeering (Kaplan)
 * Encore Medical Corporation (DJO)
 * International Medical Group
 * InTouch Health
 * JDS Pharmaceuticals (Noven)
 * lifeIMAGE
 * Lumenos (Anthem)
 * Medassets
 * Medical Imaging Holdings (Unisyn)
 * Medicode (United Healthcare)
 * MiniMed (Medtronic Minimed)
 * National Rehab Equipment (McKesson)
 * Ocular Sciences (Cooper Vision)
 * PeriGen
 * Pyxis (Cardinal Health)
 * Quotient Limited
 * Sharecare
 * SMP Pharmacy
 * SonaCare
 * Stericycle
 * Tactile Medical
 * Taro Pharmaceuticals